Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Neuropeptide Y receptor subtype 4 (Y4) is a G protein-coupled receptor primarily activated by pancreatic polypeptide (PP). It plays a key role in appetite regulation, energy homeostasis, and other physiological functions. Due to its involvement in satiety signaling, it is considered a potential therapeutic target for metabolic diseases such as obesity.
Gi/o protein-coupled; inhibits adenylyl cyclase activity and cAMP production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide Y Receptor Subtype 4 (Y₄).